These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 34569782)
21. Chemoenzymatic synthesis of glycoengineered IgG antibodies and glycosite-specific antibody-drug conjugates. Tang F; Wang LX; Huang W Nat Protoc; 2017 Aug; 12(8):1702-1721. PubMed ID: 28749929 [TBL] [Abstract][Full Text] [Related]
22. Characterization of Antibody Products Obtained through Enzymatic and Nonenzymatic Glycosylation Reactions with a Glycan Oxazoline and Preparation of a Homogeneous Antibody-Drug Conjugate via Fc N-Glycan. Manabe S; Yamaguchi Y; Matsumoto K; Fuchigami H; Kawase T; Hirose K; Mitani A; Sumiyoshi W; Kinoshita T; Abe J; Yasunaga M; Matsumura Y; Ito Y Bioconjug Chem; 2019 May; 30(5):1343-1355. PubMed ID: 30938513 [TBL] [Abstract][Full Text] [Related]
23. Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site. Kumar A; Mao S; Dimasi N; Gao C Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961794 [TBL] [Abstract][Full Text] [Related]
24. Engineering Antibodies with C-Terminal Sortase-Mediated Modification for Targeted Nanomedicine. Hashad RA; Lange JL; Tan NCW; Alt K; Hagemeyer CE Methods Mol Biol; 2019; 2033():67-80. PubMed ID: 31332748 [TBL] [Abstract][Full Text] [Related]
26. Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system. Zimmerman ES; Heibeck TH; Gill A; Li X; Murray CJ; Madlansacay MR; Tran C; Uter NT; Yin G; Rivers PJ; Yam AY; Wang WD; Steiner AR; Bajad SU; Penta K; Yang W; Hallam TJ; Thanos CD; Sato AK Bioconjug Chem; 2014 Feb; 25(2):351-61. PubMed ID: 24437342 [TBL] [Abstract][Full Text] [Related]
27. Generation of efficient mutants of endoglycosidase from Streptococcus pyogenes and their application in a novel one-pot transglycosylation reaction for antibody modification. Iwamoto M; Sekiguchi Y; Nakamura K; Kawaguchi Y; Honda T; Hasegawa J PLoS One; 2018; 13(2):e0193534. PubMed ID: 29474426 [TBL] [Abstract][Full Text] [Related]
30. Chemoenzymatic glycan-selective remodeling of a therapeutic lysosomal enzyme with high-affinity M6P-glycan ligands. Enzyme substrate specificity is the name of the game. Zhang X; Liu H; Meena N; Li C; Zong G; Raben N; Puertollano R; Wang LX Chem Sci; 2021 Sep; 12(37):12451-12462. PubMed ID: 34603676 [TBL] [Abstract][Full Text] [Related]
31. Real-Time Analysis on Drug-Antibody Ratio of Antibody-Drug Conjugates for Synthesis, Process Optimization, and Quality Control. Tang Y; Tang F; Yang Y; Zhao L; Zhou H; Dong J; Huang W Sci Rep; 2017 Aug; 7(1):7763. PubMed ID: 28798339 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of precision antibody conjugates using proximity-induced chemistry. Cao YJ; Yu C; Wu KL; Wang X; Liu D; Tian Z; Zhao L; Qi X; Loredo A; Chung A; Xiao H Theranostics; 2021; 11(18):9107-9117. PubMed ID: 34522229 [No Abstract] [Full Text] [Related]
33. One-pot N-glycosylation remodeling of IgG with non-natural sialylglycopeptides enables glycosite-specific and dual-payload antibody-drug conjugates. Tang F; Yang Y; Tang Y; Tang S; Yang L; Sun B; Jiang B; Dong J; Liu H; Huang M; Geng MY; Huang W Org Biomol Chem; 2016 Oct; 14(40):9501-9518. PubMed ID: 27714198 [TBL] [Abstract][Full Text] [Related]
34. Enzymatic glycan remodeling-metal free click (GlycoConnectâ„¢) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineering. Wijdeven MA; van Geel R; Hoogenboom JH; Verkade JMM; Janssen BMG; Hurkmans I; de Bever L; van Berkel SS; van Delft FL MAbs; 2022; 14(1):2078466. PubMed ID: 35634725 [TBL] [Abstract][Full Text] [Related]
35. Development of Solid-Phase Site-Specific Conjugation and Its Application toward Generation of Dual Labeled Antibody and Fab Drug Conjugates. Puthenveetil S; Musto S; Loganzo F; Tumey LN; O'Donnell CJ; Graziani E Bioconjug Chem; 2016 Apr; 27(4):1030-9. PubMed ID: 26942771 [TBL] [Abstract][Full Text] [Related]
36. Photoconjugation of an Fc-Specific Peptide Enables Efficient DAR 2 Antibody-Drug Conjugate Formation. Lee T; Kim JH; Kwon SJ; Park SH; Kim J; Kang HJ; Chung SJ Org Lett; 2020 Nov; 22(21):8419-8423. PubMed ID: 33074682 [TBL] [Abstract][Full Text] [Related]
37. Site Selective Antibody-Oligonucleotide Conjugation via Microbial Transglutaminase. Huggins IJ; Medina CA; Springer AD; van den Berg A; Jadhav S; Cui X; Dowdy SF Molecules; 2019 Sep; 24(18):. PubMed ID: 31509944 [TBL] [Abstract][Full Text] [Related]
38. Highly robust and optimized conjugation of antibodies to nanoparticles using quantitatively validated protocols. Jeong S; Park JY; Cha MG; Chang H; Kim YI; Kim HM; Jun BH; Lee DS; Lee YS; Jeong JM; Lee YS; Jeong DH Nanoscale; 2017 Feb; 9(7):2548-2555. PubMed ID: 28150822 [TBL] [Abstract][Full Text] [Related]
39. Glycan Remodeling of Human Erythropoietin (EPO) Through Combined Mammalian Cell Engineering and Chemoenzymatic Transglycosylation. Yang Q; An Y; Zhu S; Zhang R; Loke CM; Cipollo JF; Wang LX ACS Chem Biol; 2017 Jun; 12(6):1665-1673. PubMed ID: 28452462 [TBL] [Abstract][Full Text] [Related]
40. Development, Optimization, and Structural Characterization of an Efficient Peptide-Based Photoaffinity Cross-Linking Reaction for Generation of Homogeneous Conjugates from Wild-Type Antibodies. Vance N; Zacharias N; Ultsch M; Li G; Fourie A; Liu P; LaFrance-Vanasse J; Ernst JA; Sandoval W; Kozak KR; Phillips G; Wang W; Sadowsky J Bioconjug Chem; 2019 Jan; 30(1):148-160. PubMed ID: 30566343 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]